Miura M - Search Results

1

Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.

Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group. Noguchi S, et al. Among authors: miura m. Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30. Int J Hematol. 2018. PMID: 29713954 Clinical Trial.

2

High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.

Miura M, Takahashi N, Sawada K. Miura M, et al. Biomed Chromatogr. 2010 Jul;24(7):789-93. doi: 10.1002/bmc.1364. Biomed Chromatogr. 2010. PMID: 19904720

3

Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.

Nara M, Takahashi N, Miura M, Saitoh H, Kagaya H, Sawada K. Nara M, et al. Among authors: miura m. Am J Hematol. 2010 Aug;85(8):634-5. doi: 10.1002/ajh.21759. Am J Hematol. 2010. PMID: 20568249 Free article. No abstract available.

4

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.

Takahashi N, Miura M, Scott SA, Kagaya H, Kameoka Y, Tagawa H, Saitoh H, Fujishima N, Yoshioka T, Hirokawa M, Sawada K. Takahashi N, et al. Among authors: miura m. J Hum Genet. 2010 Nov;55(11):731-7. doi: 10.1038/jhg.2010.98. Epub 2010 Aug 19. J Hum Genet. 2010. PMID: 20720558

5

Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase.

Takahashi N, Miura M. Takahashi N, et al. Among authors: miura m. Pharmacology. 2011;87(5-6):241-8. doi: 10.1159/000324900. Epub 2011 Apr 6. Pharmacology. 2011. PMID: 21474977 Review.

6

Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.

Miura M, Takahashi N, Sawada K. Miura M, et al. J Chromatogr Sci. 2011 May;49(5):412-5. doi: 10.1093/chromsci/49.5.412. J Chromatogr Sci. 2011. PMID: 21549035

7

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.

Takahashi N, Miura M, Niioka T, Sawada K. Takahashi N, et al. Among authors: miura m. Cancer Chemother Pharmacol. 2012 Apr;69(4):999-1004. doi: 10.1007/s00280-011-1797-3. Epub 2011 Dec 7. Cancer Chemother Pharmacol. 2012. PMID: 22147077

8

Drug interaction between lenalidomide and itraconazole.

Takahashi N, Miura M, Kameoka Y, Abumiya M, Sawada K. Takahashi N, et al. Among authors: miura m. Am J Hematol. 2012 Mar;87(3):338-9. doi: 10.1002/ajh.22260. Epub 2011 Dec 27. Am J Hematol. 2012. PMID: 22213235 Free article. No abstract available.

9

Pharmacokinetics of nilotinib in imatinib-resistant/intolerant chronic myeloid leukemia patients on hemodialysis for chronic renal failure.

Onaka T, Takahashi N, Miura M, Yonezawa A, Imada K, Sawada K. Onaka T, et al. Among authors: miura m. Am J Hematol. 2012 Apr;87(4):451. doi: 10.1002/ajh.23125. Epub 2012 Mar 9. Am J Hematol. 2012. PMID: 22407703 Free article. No abstract available.

10

Bile acid is important for gastrointestinal absorption of nilotinib.

Fujimi A, Takahashi N, Miura M, Kanisawa Y, Ono K, Sawada K. Fujimi A, et al. Among authors: miura m. Eur J Clin Pharmacol. 2012 Nov;68(11):1575-6; author reply 1573-4. doi: 10.1007/s00228-012-1282-x. Epub 2012 Apr 15. Eur J Clin Pharmacol. 2012. PMID: 22527347 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,137 results

Search Page

Filters